Clinical Trial Update: Preventing ESRD in Overt Nephropathy of Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating prevention of end-stage renal disease in patients with type 2 diabetes and overt diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Diabetes | Phase 3 | Status: COMPLETED